Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
6.13
0.00 (0.00%)
Nov 20, 2024, 4:00 PM EST - Market closed
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $789.61 million as of November 21, 2024. Its market cap has increased by 30.91% in one year.
Market Cap
789.61M
Enterprise Value
526.35M
1-Year Change
30.91%
Ranking
Category
Stock Price
$6.13
Market Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $789.61M, a decrease of -65.08%. That is a compound annual growth rate of -27.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 789.61M | -36.13% |
| Dec 29, 2023 | 1.24B | -10.21% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AbCellera Biologics | 787.15M |
| Embecta | 784.74M |
| Cullinan Therapeutics | 783.16M |
| Erasca | 781.74M |
| Avid Bioservices | 781.22M |
| Castle Biosciences | 779.72M |
| Cronos Group | 775.61M |
| Pacira BioSciences | 772.48M |